<DOC>
	<DOC>NCT00619931</DOC>
	<brief_summary>The APD791-002 study is designed primarily to evaluate the safety, tolerability, and pharmacokinetics of APD791 when administered for 7 days to healthy adult subjects.</brief_summary>
	<brief_title>A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>APD791</mesh_term>
	<criteria>Healthy adult men and women, ages 1945 Non smokers History of a bleeding disorder Use of any drug known to have an effect on coagulation or clotting or any antiplatelet therapy within 2 weeks of the screening Recently donated blood or had significant blood loss Current use of a prescription medication Pregnant females</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Healthy adult volunteers</keyword>
</DOC>